Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic HSCT”

2,007 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,007 results

Testing effectiveness (Phase 2)WithdrawnNCT04720742
What this trial is testing

Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation

Who this might be right for
HIV Infection
IrsiCaixa
Testing effectiveness (Phase 2)WithdrawnNCT00148980
What this trial is testing

Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesMyelofibrosis
Hadassah Medical Organization 24
Not applicableStudy completedNCT05315882
What this trial is testing

Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA

Who this might be right for
CMV Infection
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 300
Not applicableNot Yet RecruitingNCT07552480
What this trial is testing

Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using Goserelin

Who this might be right for
Allogeneic Haematopoietic Stem Cell TransplantationMalignant Hematologic DiseaseOvarian Insufficiency
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 64
Testing effectiveness (Phase 2)Study completedNCT01323920
What this trial is testing

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Not applicableUnknownNCT05905770
What this trial is testing

Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD?

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Early research (Phase 1)Study completedNCT00968162
What this trial is testing

Sickle Cell Disease Conditioning for Bone Marrow Transplant

Who this might be right for
Bone Marrow TransplantationSickle Cell Disease
Emory University 8
Not applicableStudy completedNCT07116018
What this trial is testing

Psychoeducation for AlloHCT Caregivers

Who this might be right for
CancerCaregiversStem Cell Transplant+2 more
University Health Network, Toronto 17
Not applicableStudy completedNCT02039557
What this trial is testing

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

Who this might be right for
Patients Transplanted With NiCord/CordIn (Omidubicel)
Gamida Cell ltd 33
Early research (Phase 1)Study completedNCT01700751
What this trial is testing

Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Lymphoblastic,AcuteMyelodysplastic Syndromes
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT07232953
What this trial is testing

Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukaemia (AML)Hematopoietic Stem Cell Transplant (HSCT)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 82
Early research (Phase 1)Study completedNCT01300572
What this trial is testing

Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS

Who this might be right for
Chronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic Leukemia+3 more
Fred Hutchinson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT02250300
What this trial is testing

MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Mehdi Hamadani 68
Early research (Phase 1)Not Yet RecruitingNCT06900192
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisMultiple SclerosisMultiple Sclerosis, Primary Progressive+1 more
Stanford University 10
Not applicableStudy completedNCT01219972
What this trial is testing

Pulmonary Complications of Allografts

Who this might be right for
Pulmonary Complications
Assistance Publique - Hôpitaux de Paris 245
Very early researchStudy completedNCT02117115
What this trial is testing

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic+1 more
Washington University School of Medicine 21
Testing effectiveness (Phase 2)Ended earlyNCT00540995
What this trial is testing

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+12 more
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT05870995
What this trial is testing

Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia

Who this might be right for
Refractory Leukemia
Shanghai Jiao Tong University School of Medicine 100
Next Page